Severe hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in a 16 year old African-American male: Hypoglycemia due to insulin autoimmune syndrome
Open accessAbstract
Insulin autoimmune syndrome (IAS) or Hirata's disease is a rare disorder characterized by hypoglycemia secondary to insulin autoantibodies (IAb). Over 200 patients have been described from Japan with significantly less numbers being reported from outside the Orient. IAS is more common in patients older than 40 yr of age with reports in the pediatric age group being notably rarer. Exposure to sulfhydryl group containing medications is implicated in the pathogenesis of this syndrome. In this report, we describe a case of IAS in an African-American adolescent. A 16-yr-old healthy African-American male was diagnosed with Graves' disease and started on Methimazole. Four weeks later, he was found unconscious and hypoglycemic (blood sugar 1.5 mmol/L). Evaluation was negative for insulinoma. Insulin antibodies were positive. Oral glucose tolerance test revealed elevated free insulin concentrations with disproportionately elevated total insulin levels. The patient was started on prednisone, diazoxide, and propranolol for management of IAS and hyperthyroidism. Thyroid radio-ablation was subsequently undertaken. The doses of prednisone and diazoxide were tapered and these medications discontinued after 9 months. The insulin antibody levels decreased gradually and became undetectable in 6 months with resolution of the hypoglycemia.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rare cases of insulin autoimmune syndrome with symptomatic hypoglycemia have been reported in patients treated with MMI.
“Rare cases of insulin autoimmune syndrome with symptomatic hypoglycemia have been reported in patients treated with MMI (146,147).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [146]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Autoimmune Forms of Hypoglycemia
Lupsa, B., Chong, A., Cochran, E., Soos, M., Semple, R., & Gorden, P. (2009) · Medicine · doi:10.1097/md.0b013e3181a5b42e · Cited by 192 · see citing works
MODIFICATION BY PROPRANOLOL OF CARDIOVASCULAR EFFECTS OF INDUCED HYPOGLYCÆMIA
Lloyd‐Mostyn, R. H., & Oram, S. H. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92195-9 · Cited by 130 · see citing works
Insulin Autoimmune Syndrome (Hirata Disease): Clinical Features and Epidemiology in Japan
Uchigata, Y., Eguchi, Y., Takayama-Hasumi, S., & Omori, Y. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90040-x · Cited by 127 · see citing works
Matsushita, S., Takahashi, K., Motoki, M., Komoriya, K., Ikagawa, S., & Nishimura, Y. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.873 · Cited by 122 · see citing works
Insulin autoimmune syndrome (IAS, Hirata disease).
Uchigata, Y., & Hirata, Y. (1999) · PubMed · Cited by 109 · see citing works
Uchigata, Y., Hirata, Y., Omori, Y., Iwamoto, Y., & Tokunaga, K. (2000) · Human Immunology · doi:10.1016/s0198-8859(99)00144-5 · Cited by 99 · see citing works
Drug-induced insulin autoimmune syndrome.
Uchigata, Y., Hirata, Y., & Iwamoto, Y. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.10.015 · Cited by 97 · see citing works
Redmon, J., & Nuttall, F. (1999) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/s0889-8529(05)70090-6 · Cited by 77 · see citing works
Insulin autoimmune syndrome in Japan
Hirata, Y., & Uchigata, Y. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90243-7 · Cited by 71 · see citing works
Hyperthyroidism and Cortisol Secretion in Man
Gallagher, T. F., HELLMAN, L., Finkelstein, J. W., et al. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-6-919 · Cited by 70 · see citing works
Uchigata, Y., Kuwata, S., Tsushima, T., Tokunaga, K., Miyamoto, M., Tsuchikawa, K., Hirata, Y., Juji, T., & Omori, Y. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.1.8325948 · Cited by 67 · see citing works
HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome
Uchigata, Y. (1992) · The Lancet · doi:10.1016/0140-6736(92)92654-x · Cited by 48 · see citing works
Wang, Y.-L., Yao, P.-W., Zhang, X., Luo, Z.-Z., Wu, P., & Xiao, F. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.163376 · Cited by 45 · see citing works
Severe hypoglycemic coma due to insulin autoimmune syndrome.
Ma, W.-Y., Won, J. G., Tang, K.-T., & Lin, H.-D. (2005) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70140-6 · Cited by 28 · see citing works
Hirata, Y., & Uchigata, Y. (2025) · Egyptian Society of Diabetes and Lipidology Journal · doi:10.21608/esdlj.2025.456265 · Cited by 26 · see citing works
Bortolotti, D., Mothe‐Satney, I., Ferrari, P. P., Gautier, N., Sonke, J., Pallé, S., Bernard, G., Badetti, J., Fredenrich, A., OBBERGHEN, E. V., et al. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70314-2 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
“Rare cases of insulin autoimmune syndrome with symptomatic hypoglycemia have been reported in patients treated with MMI (146,147).”
BackgroundInsulin autoimmune syndrome: from diagnosis to clinical management
Censi, S., Mian, C., & Betterle, C. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.07.32 · Cited by 152 · see citing works
Cappellani, D., Macchia, E., Falorni, A., & Marchetti, P. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s219438 · Cited by 138 · see citing works
Recurrent Hypoglycemia from Insulin Autoimmune Syndrome
Wong, S. L., Priestman, A., & Holmes, D. T. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2588-9 · Cited by 73 · see citing works
Pediatric Graves’ disease: management in the post-propylthiouracil Era
Rivkees, S. A. (2014) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2014-10 · Cited by 46 · see citing works
“GD can be associated with either hyper- or hypoglycemia at presentation [52,53].”
Background
- Authors
- Gomez Cruz, M. J., Jabbar, M., Saini, N., Eng, D., Crawford, B., Vazquez, D. M., Menon, R., & Chen, M.
- Affiliations
- Department of Pediatrics and Communicable Diseases; C.S. Mott Children's Hospital and the University of Michigan; Ann Arbor; MI; USA
- Hurley Medical Center (US)
- Geisinger Medical Center (US)
- University of Michigan (US)
- Corresponding author
- Chen, Ming
- ORCID
- Chen, Ming
- Venue
- Pediatric Diabetes
- Publisher
- Hindawi Limited
- Published
- 2012-07-03
- Volume
- 13
- Issue
- 8
- Pages
- 652-655
- ISSN
- 1399-543X (ISSN-L)
- OpenAlex
- W1910418453
- Cited by
- 34
- References
- 16
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 2 · 2016: 5 · 2015: 3 · 2014: 2 · 2013: 3
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Pediatric Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Funders
- University of Michigan
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- insulin autoimmune syndrome, hypoglycemia, methimazole, insulin autoantibodies, Graves' disease, hyperthyroidism, prednisone, diazoxide, propranolol, adolescents, African Americans
- MeSH terms
- Adolescent, Autoantibodies, Autoimmune Diseases, Black or African American, Diazoxide, Graves Disease, Humans, Hypoglycemia, Insulin, Male, Methimazole, Prednisone, Propranolol, Antithyroid Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review